Breathtec BioMedical Inc.
Breathtec BioMedical Inc. (BTH)
Le 16 octobre/October 2018
Breathtec BioMedical Inc. has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post-consolidation share for each two (2) pre-consolidation common shares.
As a result, the outstanding shares of the company will be reduced to approximately 28,682,012.
The shares will begin trading on a consolidated basis and with a new CUSIP number on October 17, 2018.
The name and symbol will not change.